Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Charles Asakiya, Liye Zhu, Jieyu Yuhan, Longjiao Zhu, Kunlun Huang & Wentao Xu. (2022) Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications. Expert Opinion on Drug Delivery 19:4, pages 435-450.
Read now
Read now
Lihua Dong, Jingjing Huang, Peng Zu, Jing Liu, Xue Gao, Jianwei Du & Yufu Li. (2021) Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis. Bioengineered 12:1, pages 7995-8005.
Read now
Read now
Jing Xue, Jiali Yang, Meihui Luo, William C. Cho & Xiaoming Liu. (2017) MicroRNA-targeted therapeutics for lung cancer treatment. Expert Opinion on Drug Discovery 12:2, pages 141-157.
Read now
Read now
Articles from other publishers (33)
Yongan Song, Leonardo Kelava & István Kiss. (2023) MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy. International Journal of Molecular Sciences 24:17, pages 13302.
Crossref
Crossref
Alti Dayakar, Kumar D. Shanmukha & Suresh K. Kalangi. (2022) Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy. Molecular Biology Reports 49:7, pages 6827-6846.
Crossref
Crossref
Yunhua Guo, Jianpu Tang, Chi Yao & Dayong Yang. (2021)
Multimodules integrated functional
DNA
nanomaterials for intelligent drug delivery
. WIREs Nanomedicine and Nanobiotechnology 14:1.
Crossref
Crossref
Shadab Md, Nabil A. Alhakamy, Shahid Karim, Gamal A Gabr, Mohammad Kashif Iqubal & Samar S. A. Murshid. (2021) Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review. Pharmaceutics 13:12, pages 2120.
Crossref
Crossref
Soha Reda El Sayed, Justine Cristante, Laurent Guyon, Josiane Denis, Olivier Chabre & Nadia Cherradi. (2021) MicroRNA Therapeutics in Cancer: Current Advances and Challenges. Cancers 13:11, pages 2680.
Crossref
Crossref
Sachchida Nand Pandey. 2021. Skin Cancer: Pathogenesis and Diagnosis. Skin Cancer: Pathogenesis and Diagnosis
101
130
.
Nicholas J. Monteleone & Carol S. Lutz. (2020) miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells. Oncotarget 11:51, pages 4699-4721.
Crossref
Crossref
Qiushuang Zhang, Fei Ding, Xinlong Liu, Jian Shen, Yue Su, Jiwen Qian, Xinyuan Zhu & Chuan Zhang. (2020) Nanobody-guided targeted delivery of microRNA via nucleic acid nanogel to inhibit the tumor growth. Journal of Controlled Release 328, pages 425-434.
Crossref
Crossref
Margherita Ratti, Andrea Lampis, Michele Ghidini, Massimiliano Salati, Milko B. Mirchev, Nicola Valeri & Jens C. Hahne. (2020) MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Targeted Oncology 15:3, pages 261-278.
Crossref
Crossref
Monica Neagu, Carolina Constantin, Sanda Maria Cretoiu & Sabina Zurac. (2020) miRNAs in the Diagnosis and Prognosis of Skin Cancer. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Qing‐feng Ni, Yan Zhang, Jia‐wei Yu, Ru‐heng Hua, Qu‐hui Wang & Jian‐wei Zhu. (2019) miR‐92b promotes gastric cancer growth by activating the DAB2IP‐mediated PI3K/AKT signalling pathway. Cell Proliferation 53:1.
Crossref
Crossref
Lin Fu, Jialei Qi, Xiang Gao, Ninghan Zhang, Huihui Zhang, Rong Wang, Linyan Xu, Yao Yao, Mingshan Niu & Kailin Xu. (2019) High expression of miR‐338 is associated with poor prognosis in acute myeloid leukemia undergoing chemotherapy. Journal of Cellular Physiology 234:11, pages 20704-20712.
Crossref
Crossref
Maria Angelica Cortez, Simone Anfossi, Rishab Ramapriyan, Hari Menon, Semra Cemre Atalar, Maureen Aliru, James Welsh & George A. Calin. (2019) Role of miRNAs in immune responses and immunotherapy in cancer. Genes, Chromosomes and Cancer 58:4, pages 244-253.
Crossref
Crossref
Lucy Wanjiku Macharia, Caroline Muriithi Wanjiru, Marianne Wanjiru Mureithi, Claudia Maria Pereira, Valéria Pereira Ferrer & Vivaldo Moura-Neto. (2019) MicroRNAs, Hypoxia and the Stem-Like State as Contributors to Cancer Aggressiveness. Frontiers in Genetics 10.
Crossref
Crossref
Jing Yu, Yifan Lv, Fengliang Wang, Xiaocen Kong, Wenjuan Di, Juan Liu, Yunlu Sheng, Shan Lv & Guoxian Ding. (2019) MiR-27b-3p Inhibition Enhances Browning of Epididymal Fat in High-Fat Diet Induced Obese Mice. Frontiers in Endocrinology 10.
Crossref
Crossref
Yu Hu, Hayley Dingerdissen, Samir Gupta, Robel Kahsay, Vijay Shanker, Quan Wan, Cheng Yan & Raja Mazumder. (2018) Identification of key differentially expressed MicroRNAs in cancer patients through pan-cancer analysis. Computers in Biology and Medicine 103, pages 183-197.
Crossref
Crossref
Wei Wang, Peng Lin, Haiying Yao, Xi Jia, Jirui Sun & Lin Feng. (2018) MicroRNA-4728 serves as a suppressor and antagonist of oncogenic MAPK in Burkitt lymphoma. Saudi Journal of Biological Sciences 25:5, pages 982-985.
Crossref
Crossref
Dipta Sengupta, Moonmoon Deb & Samir Kumar Patra. (2018) Antagonistic activities of miR-148a and DNMT1: Ectopic expression of miR-148a impairs DNMT1 mRNA and dwindle cell proliferation and survival. Gene 660, pages 68-79.
Crossref
Crossref
Jie Li, Yuanhui Lai, Jieyi Ma, Yue Liu, Jiong Bi, Longjuan Zhang, Lianzhou Chen, Chen Yao, Weiming Lv, Guangqi Chang, Shenming Wang, Mao Ouyang & Wenjian Wang. (2017) miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer. BMC Cancer 17:1.
Crossref
Crossref
Minghao Xie, Huabo Qin, Qianxin Luo, Qunsheng Huang, Xiaosheng He, Zihuan Yang, Ping Lan & Lei Lian. (2017) MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73. BMC Cancer 17:1.
Crossref
Crossref
Nilesh Kalariya, Kelly Brassil & George Calin. (2017) MicroRNAs: Clinical Trials and Potential Applications
. Clinical Journal of Oncology Nursing 21:5, pages 554-559.
Crossref
Crossref
Jisce R Puik, Laura L Meijer, Tessa YS Le Large, Mireia Mato Prado, Adam E Frampton, Geert Kazemier & Elisa Giovannetti. (2017) miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma. Pharmacogenomics 18:14, pages 1343-1358.
Crossref
Crossref
Lauren Anton, Ann DeVine, Luz-Jeannette Sierra, Amy G. Brown & Michal A. Elovitz. (2017) miR-143 and miR-145 disrupt the cervical epithelial barrier through dysregulation of cell adhesion, apoptosis and proliferation. Scientific Reports 7:1.
Crossref
Crossref
Lobna Elkhadragy, Minyi Chen, Kennon Miller, Muh-Hwa Yang & Weiwen Long. (2017) A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells. Molecular Oncology 11:2, pages 194-207.
Crossref
Crossref
Andrew J. Stacy, Michael P. Craig, Suraj Sakaram & Madhavi Kadakia. (2016) ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition. Oncotarget 8:2, pages 2114-2129.
Crossref
Crossref
Lu-Jia Chen, Lian Yang, Xing Cheng, Yin-Kai Xue & Li-Bo Chen. (2017) Overexpression of miR-24 Is Involved in the Formation of Hypocoagulation State after Severe Trauma by Inhibiting the Synthesis of Coagulation Factor X. Disease Markers 2017, pages 1-7.
Crossref
Crossref
Edoardo Missiaglia, Chris J. Shepherd, Ewa Aladowicz, David Olmos, Joanna Selfe, Ga?lle Pierron, Olivier Delattre, Zoe Walters & Janet Shipley. (2017) MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas. Cancer Letters 385, pages 251-260.
Crossref
Crossref
Bo Jiang, Yanan Huo, Yangshun Gu & Jianyong Wang. (2016) The role of microRNAs in myopia. Graefe's Archive for Clinical and Experimental Ophthalmology 255:1, pages 7-13.
Crossref
Crossref
Cong-Qiu ChuCong-Qiu Chu. 2017. Targeting the IL-17 Pathway in Inflammatory Disorders. Targeting the IL-17 Pathway in Inflammatory Disorders
55
99
.
Cameron P. Bracken, Hamish S. Scott & Gregory J. Goodall. (2016) A network-biology perspective of microRNA function and dysfunction in cancer. Nature Reviews Genetics 17:12, pages 719-732.
Crossref
Crossref
Tomas Barta, Lucie Peskova & Ales Hampl. (2016) miRNAsong: a web-based tool for generation and testing of miRNA sponge constructs in silico. Scientific Reports 6:1.
Crossref
Crossref
Samayita Das. (2016) Identification and targeting of microRNAs modulating acquired chemotherapy resistance in Triple negative breast cancer (TNBC): A better strategy to combat chemoresistance. Medical Hypotheses 96, pages 5-8.
Crossref
Crossref
Yang Li, Xianfeng Zhang, Dawei Chen & Chengyuan Ma. (2015) Let-7a suppresses glioma cell proliferation and invasion through TGF-?/Smad3 signaling pathway by targeting HMGA2. Tumor Biology 37:6, pages 8107-8119.
Crossref
Crossref